Brought to you by:
Study: Early thrombosis after iliac stenting for venous outflow occlusion is related to disease severity, anticoagulation type
Fewer than 10 days of low-molecular-weight heparin (LMWH) after stenting for extensive iliofemoral venous occlusion prior to transition to oral anticoagulation reduces early thrombosis, according to a multicenter study. Thrombosis following iliofemoral venous stenting is frustrating to both the patient…
VEITH 2021: Researchers present ex vivo demonstration of fluoroscopy-free complex AAA stent placement
“I think this represents the beginning of the end of an era where we have to use lead to perform these procedures.” Those were the words delivered by Gustavo Oderich, MD, professor and chief of vascular and endovascular surgery at…
VEITH 2021: Two-year follow-up data from EVAS2 IDE study delivered
The confirmatory EVAS2 clinical study to evaluate the safety and effectiveness of Endologix’s Nellix endovascular aneurysm sealing system (EVAS) for the treatment of infrarenal abdominal aortic aneurysms (AAAs) contains positive two-year follow-up data, the leading investigator has revealed. A first…
Viz.ai reveals launch of new AI-powered modules for pulmonary embolism, aortic disease
Viz.ai—a company focused on artificial intelligence (AI)-driven intelligent care coordination—today announced the U.S. commercial launch of its AI-powered modules for pulmonary embolism (PE) and aortic disease at the 2021 VEITHsymposium (Nov. 16–20) in Orlando, Florida. The new modules allow for…
Interview: The value and utility of surgical sketches
W. Michael Park, MD, was first turned onto the utility and wonder of anatomical sketching during medical school. Back then, he developed an affinity for the visual-learning benefits afforded by his own hand and for how much better it allowed…
IN.PACT Admiral DCB performs well across wide range of clinical, anatomical scenarios in pooled analysis
In a pooled analysis of the predictors of drug-coated balloon (DCB) effectiveness, the IN.PACT Admiral DCB (Medtronic) performed well across a broad range of clinical, anatomical and procedural scenarios. This is according to Prakash Krishnan, MD, an interventional cardiologist at Mount Sinai…
Take advantage of SVS diabetes resources
November is National Diabetes Month. The Society for Vascular Surgery (SVS) has many resources to help its members educate their patients and families and reach out to referring podiatrists and other providers. Members can customize many of the resources with…
Hispanic adults with PAD access inpatient care most often via the emergency room
Hispanic adults hospitalized for treatment of symptoms of peripheral arterial disease (PAD) were more likely to access this care by going to the emergency room (ER), and they experienced longer and more expensive hospitalizations than non-Hispanic white patients with PAD,…
Benefits of percutaneous fistula creation further bolstered by five-year Ellipsys data
The Ellipsys vascular access system (Avenu Medical/Medtronic) can be used to easily and safely create durable percutaneous arteriovenous fistulas (pAVFs) for haemodialysis—with new, long-term data suggesting it offers an “excellent alternative” to AVF creation via surgical procedures in end-stage renal…
Philips announces large-scale study outcomes on use of IVUS in peripheral interventions
Royal Philips has announced the results of a new large-scale real-world analysis of Centers for Medicare & Medicaid Services (CMS) data on the health outcomes of peripheral vascular interventions guided by intravascular ultrasound (IVUS). The study was conducted independently by…